Fund comparison · from official SEC filings

BIB vs IBBQ: how much do they overlap?

ProShares Ultra Nasdaq Biotechnology and Invesco Nasdaq Biotechnology ETF
Holdings overlap
70%
of assets, by weight
Shared positions
255
of 259 / 259 holdings
BIB expense ratio
0.95%
net, per year
IBBQ expense ratio
0.19%
net, per year
BIB and IBBQ are largely redundant — holding both means most of your money tracks the same underlying companies.
Shared holdings
Company
BIB
IBBQ
G
GILDGILEAD SCIENCES INC
5.19%
6.18%
V
VRTXVERTEX PHARMACEUTICALS INC
5.18%
6.17%
A
AMGNAMGEN INC
4.99%
5.94%
R
REGNREGENERON PHARMACEUTICALS
3.57%
4.25%
A
ALNYALNYLAM PHARMACEUTICALS INC
2.24%
2.67%
R
RVMDREVOLUTION MEDICINES INC
1.74%
2.08%
B
BIIBBIOGEN INC
1.61%
1.91%
I
ILMNILLUMINA INC
1.39%
1.66%
U
UTHRUNITED THERAPEUTICS CORP
1.36%
1.62%
R
RPRXROYALTY PHARMA PLC- CL A
1.34%
1.59%
A
ARGXARGENX SE - ADR
1.33%
1.58%
I
INSMINSMED INC
1.29%
1.53%
R
ROIVROIVANT SCIENCES LTD
1.20%
1.43%
I
INCYINCYTE CORP
1.08%
1.28%
V
VTRSVIATRIS INC
1.05%
1.25%
M
MRNAMODERNA INC
1.04%
1.24%
G
GHGUARDANT HEALTH INC
0.95%
1.13%
N
NBIXNEUROCRINE BIOSCIENCES INC
0.89%
1.06%
J
JAZZJAZZ PHARMACEUTICALS PLC
0.81%
0.97%
A
ASNDASCENDIS PHARMA A/S
0.77%
0.92%
S
SMMTSUMMIT THERAPEUTICS INC
0.76%
0.91%
A
AGPXXINVESCO GVT & AGNCY-INST
0.90%
0.01%
E
EXELEXELIXIS INC
0.73%
0.87%
B
BBIOBRIDGEBIO PHARMA INC
0.72%
0.85%
M
MEDPMEDPACE HOLDINGS INC
0.71%
0.84%
Only in BIB
?
N/A
17.83%
I
IQMMPROSHARES GENIUS MNY MKT ETF
7.57%
?
Repurchase Agreement
3.50%
?
Cartesian Therapeutics, Inc.
0.00%
Only in IBBQ
?
Invesco Private Prime Fund
11.88%
?
Invesco Private Government Fund
4.58%
R
RNACCARTESIAN THERAPEUTICS INC
0.00%
?
Novo Nordisk A/S
0.00%
Hold BIB and IBBQ together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.